Insys Therapeutics (INSY) Stock Falls -73.9%: How Does it Score?


Insys Therapeutics Inc (INSY) stock is down -74% Monday. INSY stock is lower by -87.23% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives INSY stock a score of 23 out of a possible 100.

That score is chiefly influenced by a short-term technical score of 0. INSY’s score also includes a long-term technical score of 1. The fundamental score for INSY is 68. In addition to the average rating from Wall Street analysts, INSY stock has a mean target price of $7.60. This means analysts expect the stock to rise 708.51% over the next 12 months.

Click Here to get the full Stock Score Report on Insys Therapeutics Inc (INSY).

What’s Happening with INSY Stock Today

Insys Therapeutics Inc (INSY) stock is down -73.93% while the S&P 500 is down -2.25% as of 11:30 AM on Monday, May 13. INSY is down -$2.66 from the previous closing price of $3.60 on volume of 4,560,468 shares. Over the past year the S&P 500 has gained 3.17% while INSY is down -87.23%. INSY lost -$1.68 per share in the over the last 12 months.

Symbols: INSY

You May Also Like